- Full Text
- Scholarly Journal
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
Preview author details
; Preview author details
; Preview author details
; Preview author details
; Preview author details
; et al.
The Journal of Clinical Investigation
Preview publication details
; Ann Arbor Vol. 123, Iss. 10, (Oct 2013): 4144-57.